189 related articles for article (PubMed ID: 27082596)
1. Association Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study.
Peng YC; Lin CL; Yeh HZ; Chang CS; Wu YL; Kao CH
Medicine (Baltimore); 2016 Apr; 95(15):e3363. PubMed ID: 27082596
[TBL] [Abstract][Full Text] [Related]
2. Proton Pump Inhibitors Augment the Risk of Major Adverse Cardiovascular Events and End-Stage Renal Disease in Patients With Acute Kidney Injury After Temporary Dialysis.
Tsai IJ; Lai TS; Shiao CC; Huang TM; Wang CH; Tsao CH; Chen LW; Lin YH; Chen L; Wu VC; Chu TS;
Clin Pharmacol Ther; 2020 Jun; 107(6):1434-1445. PubMed ID: 31901200
[TBL] [Abstract][Full Text] [Related]
3. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
[TBL] [Abstract][Full Text] [Related]
4. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
[TBL] [Abstract][Full Text] [Related]
5. Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.
Klatte DCF; Gasparini A; Xu H; de Deco P; Trevisan M; Johansson ALV; Wettermark B; Ärnlöv J; Janmaat CJ; Lindholm B; Dekker FW; Coresh J; Grams ME; Carrero JJ
Gastroenterology; 2017 Sep; 153(3):702-710. PubMed ID: 28583827
[TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
[TBL] [Abstract][Full Text] [Related]
7. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease.
Chen CH; Lin HC; Lin HL; Lin YT; Chou JM; Hsu SP; Fung CP
J Microbiol Immunol Infect; 2015 Aug; 48(4):390-6. PubMed ID: 24291618
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
[TBL] [Abstract][Full Text] [Related]
10. On pump versus off pump coronary artery bypass grafting in patients with end-stage renal disease and coronary artery disease - A nation-wide, propensity score matched database analyses.
Chen JJ; Lin LY; Yang YH; Hwang JJ; Chen PC; Lin JL; Chi NH
Int J Cardiol; 2017 Jan; 227():529-534. PubMed ID: 27836299
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor use significantly increases the risk of cryptogenic liver abscess: a population-based study.
Wang YP; Liu CJ; Chen TJ; Lin YT; Fung CP
Aliment Pharmacol Ther; 2015 Jun; 41(11):1175-81. PubMed ID: 25871643
[TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
Xie Y; Bowe B; Li T; Xian H; Balasubramanian S; Al-Aly Z
J Am Soc Nephrol; 2016 Oct; 27(10):3153-3163. PubMed ID: 27080976
[TBL] [Abstract][Full Text] [Related]
13. Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.
Yu KH; Kuo CF; Chou IJ; Chiou MJ; See LC
Int J Rheum Dis; 2016 Nov; 19(11):1175-1182. PubMed ID: 26864331
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitors use and risk of chronic kidney disease in diabetic patients.
Yang H; Juang SY; Liao KF
Diabetes Res Clin Pract; 2019 Jan; 147():67-75. PubMed ID: 30500543
[TBL] [Abstract][Full Text] [Related]
15. Association between recent use of proton pump inhibitors and nontyphoid salmonellosis: a nested case-control study.
Wu HH; Chen YT; Shih CJ; Lee YT; Kuo SC; Chen TL
Clin Infect Dis; 2014 Dec; 59(11):1554-8. PubMed ID: 25091310
[TBL] [Abstract][Full Text] [Related]
16. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
[TBL] [Abstract][Full Text] [Related]
17. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study.
Hálfdánarson ÓÖ; Fall K; Ogmundsdottir MH; Lund SH; Steingrímsson E; Ogmundsdottir HM; Zoega H
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):471-478. PubMed ID: 30565786
[TBL] [Abstract][Full Text] [Related]
20. Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study.
Peng YC; Lin CL; Hsu WY; Chow WK; Lee SW; Yeh HZ; Chen CC; Kao CH
Front Pharmacol; 2018; 9():718. PubMed ID: 30018559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
